Investcorp invests in Wuhan’s leading medical testing group, Kindstar


Bahrain – Investcorp, a leading global provider and manager of alternative investment products, today announced that it has made a strategic growth investment in Kindstar lobalgene (“Kindstar”), the leading independent medical testing services group in China.

Terms of the transaction were not disclosed.Founded in 2003 and headquartered in Wuhan, Kindstar is a leading independent medical testing provider in China, offering patients and physicians broad access to advanced specialty testing services across hematology, gynecology and pediatrics, infectious diseases, oncology and neurology.Kindstar currently serves more than 3,000 hospitals in over 600 cities in China with advanced and nationally accredited clinical testing, scientific research and development laboratories and more than 2,500 employees.Hazem Ben-Gacem, Co-CEO of Investcorp, stated: “Investcorp is proud of its Asian investment platform that it has built over the past five years. Our focus on healthcare opportunities more...